133 related articles for article (PubMed ID: 38112225)
1. Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain.
Sabattini S; Baldassarro VA; Zaccone R; Calzà L; Giardino L; Vascellari M; Lorenzini L; Moretti M; Marconato L
Vet Comp Oncol; 2024 Mar; 22(1):70-77. PubMed ID: 38112225
[TBL] [Abstract][Full Text] [Related]
2. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.
Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF
BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752
[TBL] [Abstract][Full Text] [Related]
3. miRNA profiles of canine cutaneous mast cell tumours with early nodal metastasis and evaluation as potential biomarkers.
Zamarian V; Ferrari R; Stefanello D; Ceciliani F; Grieco V; Minozzi G; Chiti LE; Arigoni M; Calogero R; Lecchi C
Sci Rep; 2020 Nov; 10(1):18918. PubMed ID: 33144602
[TBL] [Abstract][Full Text] [Related]
4. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
Davies O; Taylor AJ
Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
[TBL] [Abstract][Full Text] [Related]
5. Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study.
Hillman A; Swafford B; Delavenne C; Fieten H; Boerkamp K; Tietje K
Vet Comp Oncol; 2023 Dec; 21(4):700-708. PubMed ID: 37635246
[TBL] [Abstract][Full Text] [Related]
6. Immunodetection of the signal transducer and activator of transcription-3 in canine haemangioma and haemangiosarcoma.
Petterino C; Rossetti E; Drigo M
Res Vet Sci; 2006 Apr; 80(2):186-8. PubMed ID: 16098550
[TBL] [Abstract][Full Text] [Related]
7. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma.
Dickerson EB; Thomas R; Fosmire SP; Lamerato-Kozicki AR; Bianco SR; Wojcieszyn JW; Breen M; Helfand SC; Modiano JF
Vet Pathol; 2005 Sep; 42(5):618-32. PubMed ID: 16145208
[TBL] [Abstract][Full Text] [Related]
8. Big endothelin-1 as a tumour marker for canine haemangiosarcoma.
Fukumoto S; Miyasho T; Hanazono K; Saida K; Kadosawa T; Iwano H; Uchide T
Vet J; 2015 Jun; 204(3):269-74. PubMed ID: 25920760
[TBL] [Abstract][Full Text] [Related]
9. Identification of serum microRNAs with differential expression between dogs with splenic masses and healthy dogs with histologically normal spleens.
Grimes JA; Robinson KR; Bullington AM; Schmiedt JM
Am J Vet Res; 2021 Aug; 82(8):659-666. PubMed ID: 34296940
[TBL] [Abstract][Full Text] [Related]
10. Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing.
Liu C; Ge YY; Xie XX; Luo B; Shen N; Liao XS; Bi SQ; Xu T; Xiao SW; Zhang QM
Curr Med Sci; 2021 Apr; 41(2):356-367. PubMed ID: 33877554
[TBL] [Abstract][Full Text] [Related]
11. Serum vascular endothelial growth factor in dogs with haemangiosarcoma and haematoma.
Frenz M; Kaup FJ; Neumann S
Res Vet Sci; 2014 Oct; 97(2):257-62. PubMed ID: 25241388
[TBL] [Abstract][Full Text] [Related]
12. Tumour suppressor gene p53 mutation in a case of haemangiosarcoma of a dog.
Mayr B; Zwetkoff S; Schaffner G; Reifinger M
Acta Vet Hung; 2002; 50(2):157-60. PubMed ID: 12113170
[TBL] [Abstract][Full Text] [Related]
13. Canine Cutaneous Haemangiosarcoma: Biomarkers and Survival.
Nóbrega DF; Sehaber VF; Madureira R; Bracarense APFRL
J Comp Pathol; 2019 Jan; 166():87-96. PubMed ID: 30691610
[TBL] [Abstract][Full Text] [Related]
14. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
Bray JP; Orbell G; Cave N; Munday JS
J Small Anim Pract; 2018 Feb; 59(2):85-91. PubMed ID: 29210452
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.
Heishima K; Mori T; Sakai H; Sugito N; Murakami M; Yamada N; Akao Y; Maruo K
PLoS One; 2015; 10(9):e0137361. PubMed ID: 26335793
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic miRNAs expression are different between primary and metastatic melanoma cells.
Hino Y; Rahman MM; Lai YC; Husna AA; Chen HW; Hasan MN; Nakagawa T; Miura N
Gene; 2021 May; 782():145552. PubMed ID: 33705812
[TBL] [Abstract][Full Text] [Related]
17. Haemangiosarcoma in German shepherd dogs.
Sargan D
Vet Rec; 2007 May; 160(19):672. PubMed ID: 17496285
[No Abstract] [Full Text] [Related]
18. Overexpression of Peroxiredoxin 6 Protects Neoplastic Cells against Apoptosis in Canine Haemangiosarcoma.
Anwar Sh; Yanai T; Sakai H
J Comp Pathol; 2016 Jul; 155(1):29-39. PubMed ID: 27306414
[TBL] [Abstract][Full Text] [Related]
19. Detection of novel polymorphisms in the ckit gene of canine patients with lymphoma, melanoma, haemangiosarcoma, and osteosarcoma.
Gramer I; Kessler M; Geyer J
Vet Res Commun; 2016 Jun; 40(2):89-95. PubMed ID: 26971271
[TBL] [Abstract][Full Text] [Related]
20. Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
Borgatti A; Fieberg A; Winter AL; Stuebner K; Taras E; Todhunter D; Masyr A; Rendhal A; Vallera DA; Koopmeiners JS; Modiano JF
Vet Comp Oncol; 2020 Dec; 18(4):664-674. PubMed ID: 32187827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
